{"name":"Cellect Biotechnology","slug":"cellect-biotechnology","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOSFdiWm5HY1RtOFdFVFlsNFZIUDBKU1JnSFFmUU04cFV1OWNmVGl6LW5zUXBBMkVNczFYTjlRVFFhSmowUVdRaGprNW5UUUpicjM2NDBPa21FeWxhRFVwNy1GNXFQWTlST3A5dENuU0dGOGRjS1hJZmQyUmQ0SnRyVDhFdV9wMnJ3R2NPNVp5b2NzYzlyNlRzbGpCeFhSblRWc09ySw?oc=5","date":"2025-05-01","type":"pipeline","source":"in.investing.com","summary":"Quoin Pharmaceuticals regains Nasdaq compliance By Investing.com - in.investing.com","headline":"Quoin Pharmaceuticals regains Nasdaq compliance By Investing.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQaHNBa1B1RGtLTGpZVkJPU2s4MVg1WXR6RWhmZnhwSW41Zl9TY2hWQ0lqOTVPS0JxZHlNY1p0X0M0SE5rTWhMbGRlbENjY1VzOHptdEI0SzIyNWExdVY4QVpVQW5OUjZHSFFKdFMtT0Q3Z1JPaWN3R0lueHBJMXJPUlJmVXFQZmdTRXRZdzBrdF9qdk93ek8zMkkwQ21HZEl2SnhQOXhCak15QkJ4U01ObWZic2QtRzF0aHI0NHVvbW9IY3ZZTjRjTg?oc=5","date":"2024-10-01","type":"patent","source":"reuters.com","summary":"Patent Term Adjustment and Double Patenting After In re Cellect - reuters.com","headline":"Patent Term Adjustment and Double Patenting After In re Cellect","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPeVpVOTJYSzg1Y1ZYS0NrdWZiUzRjQmJwenYzT0tsaEN3cG1mTkRjcVlYQ3dHa2xYekNWamdJVFF2Q25pVEdLb254UEU2SnBCR1RyZ25mNTdLN01FT3hZXzVhUV9lc1ByeHNWTWhFSjdkbVdhM1B3aFkzXzMyLWdCZDNNTE5sVXZqNHo1Ulc5dGNSd1FmX0VuaWtPNEpvWXBuTFI4bTRPajRqOFd0cmpzRklhZjdoM1BEbFE?oc=5","date":"2021-12-07","type":"pipeline","source":"PharmaTimes","summary":"The ecosystem overtakes the producers in pharma and life sciences - PharmaTimes","headline":"The ecosystem overtakes the producers in pharma and life sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPejRVVE1MQjQyckozelIxZHA0OGVzdm9aamxLSmxWRmVzakdIZGZhSHJWZngxSkpaOHE2ZEREMUs4ZXZ0YTB1Y1FodXA0ZWxORERaazY3RzhDYlZZNDdsLXk5QWFpTUZTNlp5S2xiS0FPMkJxODdZTkoxai1KOTV3ZjNSUzNLNmVBLWJibjVqMFU4bVFuYXFISWxqN2NFOHVhNkYyb094TFhEWXFNcHdvTlhvcWw5Njk0?oc=5","date":"2021-07-19","type":"pipeline","source":"InvestorPlace","summary":"Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace","headline":"Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPZkhZM1ZsYXJKM0l1WHAtSkphSW1NbmJjNk9rb3UzcUdKYXJEb3A4dk91MnotZ2lWTmdaY2U1UmdaY3FNZi1PcU1jbFlpb2R0dHJwdldidlVmdGlaUTQ3QU5haEhSZ0tSMWtsVGpYTGlwdEVMR09yUUdRWlg0M3h6M3JSRzRlY3dReV96LW9uX0lXY2hnOGx1NjUtNUxpRWNWY29lOFRsMVYwN3VjMnNaeXM4dzJrdEU?oc=5","date":"2021-06-21","type":"deal","source":"Business Insider","summary":"Stocks to Buy: Shares That May See a Big Short Squeeze This Week: Fintel - Business Insider","headline":"Stocks to Buy: Shares That May See a Big Short Squeeze This Week: Fintel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQX29xTERmZW53QVozRk4ySnhlZ1RkYm9YRnoxZW1TdnI4a2Zwb21zc2NnMXhIR3M4OWk5VHZYcGtWcEF6RDhjWlNVVE41UmQtbnhTN2FZa0pyTnRwbEFSNnNjY2JwQVpFU1JrOWhoZ3IycGRyVmlkOWplZ2RrVVZzWmw3UmZJRExDRXBGYTQ3a2t5NXFicXRiaWNtVER5Qnd3Q01n?oc=5","date":"2021-02-01","type":"pipeline","source":"Globes - Israel Business News","summary":"Kadimastem hopes to turn corner with new management - Globes - Israel Business News","headline":"Kadimastem hopes to turn corner with new management - Globes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFBudDJSd1RGamhVRDBtR040SUdacDdCRk80LUJuUTVMN0tXaW5tQVhpSWhmMGlqZjlxcVlMUDc3eEp2Yk9tRENWU1FfRWJ5RG05QzZ1RHNWUWpSVVR0cEpPMFU2dGQ0anYzbjVOUnZDOEVfMDhn?oc=5","date":"2020-07-16","type":"pipeline","source":"Nanalyze","summary":"Investing in Life Sciences Stocks and Companies - Nanalyze","headline":"Investing in Life Sciences Stocks and Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPa1BBSF9RbVBIUGFoV1NqLXlKUWNQblJfak1aS25sX0owNFFSNDRjdVo3QVFWNzRXSExCZXlkTkEwY1R5ZmxvQUtYb1RYd0JHbnZTUlJhMXpNcFRtQU5veUxrbGtyMk0tS0M4Uk9PNHZZSjFLVGN4YlYzcXVXb25TVTBIRVhmLXF6WUE4UTlYM1hublNVdXJsMWZiZEx6R19QUE1jS3pka0Z6MnFZNUk2d1FoMFkwTUdTdzZB?oc=5","date":"2020-03-05","type":"deal","source":"PR Newswire","summary":"Canndoc and Super-Pharm Sign Long-Term Partnership Agreement - PR Newswire","headline":"Canndoc and Super-Pharm Sign Long-Term Partnership Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFAzV3hWYnlBQWp3OUxWWk1aZ195LVZ2VWFHNkt2MzZheE05MTVlWVJMZUx3SmxfQ19YLTJDU0xQeng4emVoa3puWVR3VlhubmlRWGZtd1g3OW1yNGJGd21fLXhJU1ZKZ21VcTMwV2RhUDdoZGFf?oc=5","date":"2014-09-08","type":"deal","source":"Nanalyze","summary":"Regen Biopharma IPO: Buyer Beware - Nanalyze","headline":"Regen Biopharma IPO: Buyer Beware","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPY09fcGJDMVVLNlg0WGdVdGdjTzVLTS13VVE2MHUyM29ycVFvYjh4NVRPZmZWZ1RTTXZ1Y25sSUpxQzR6SGFILWM3bUYxRXNWSkFMSC0yeTBPUWRqeXhnMVpoalFXeTF0UTVuNWhpR2dFTXowQUdPaDJkV3VQUzhmYUVJaktVUHhYSDJB?oc=5","date":"2014-03-22","type":"pipeline","source":"Nanalyze","summary":"Big Red Flags from Bio-Matrix and Regen Biopharma - Nanalyze","headline":"Big Red Flags from Bio-Matrix and Regen Biopharma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}